SupplementalRecordSet
Element Information
Model
Attributes
| QName | Type | Fixed | Default | Use | Inheritable | Annotation |
|---|---|---|---|---|---|---|
| LanguageCode | restriction of xs:token | required |
Source
<xs:element name="SupplementalRecordSet"> <xs:complexType> <xs:sequence> <xs:element minOccurs="0" maxOccurs="unbounded" ref="SupplementalRecord"/> </xs:sequence> <xs:attributeGroup ref="attlist.SupplementalRecordSet"/> </xs:complexType> </xs:element> |
Sample
|
C114158 |
|
quantum dye macrocyclic europium-chelate |
|
1998 |
|
09 |
|
14 |
|
2003 |
|
08 |
|
08 |
|
a macrocyclic europium-chelate; structure in first source |
|
2 |
|
*D005063 |
|
Europium |
|
*D009942 |
|
Organometallic Compounds |
|
Glycobiology 1998 Sep;8(9):849-56 |
|
M0294520 |
|
quantum dye macrocyclic europium-chelate |
|
0 |
|
T324525 |
|
quantum dye macrocyclic europium-chelate |
|
NLM (1998) |
|
T324524 |
|
QD macrocyclic |
|
NLM (1998) |
|
C008718 |
|
osteoclast activating factor |
|
1974 |
|
01 |
|
01 |
|
1982 |
|
07 |
|
28 |
|
found in supernatants of cultured human leukocytes; assayed by ability to stimulate bone resorption in organ culture in mechanism of localized bone loss |
|
81 |
|
*D008222 |
|
Lymphokines |
|
D001862 |
|
Bone Resorption |
|
D010010 |
|
Osteoclasts |
|
Ann N Y Acad Sci 230(0):474;1974 |
|
Ann N Y Acad Sci 256(0):133;1975 |
|
Calcif Tissue Int 1979;29(3):201 |
|
Calcif Tissue Res 1979;28(1):23 |
|
Cell Immunol 1980;49(1):74 |
|
Eur J Immunol 6:732;1976 |
|
J Clin Invest 64(1):337;1979 |
|
J Exp Med 149(1):279;1979 |
|
J Lab Clin Med 92(5):772;1978 |
|
Surg Clin North America 57(3):543;1977 |
|
WE 200 M486:127;1977 |
|
WE 200 M486:13;1977 |
|
WE 200 M486:319;1977 |
|
M0052808 |
|
osteoclast activating factor |
|
64060-24-8 |
|
T082811 |
|
osteoclast activating factor |
|
NLM (1974) |
|
C008720 |
|
otoline |
|
1974 |
|
01 |
|
01 |
|
1995 |
|
07 |
|
21 |
|
analog of cpd 48-80; oligomeric product (n-6-8); Russian drug |
|
0 |
|
*D011108 |
|
Polymers |
|
D006636 |
|
Histamine Release |
|
Q000187 |
|
drug effects |
|
Farmakol Toksikol 36(5):614;1973 |
|
M0052812 |
|
otoline |
|
50643-04-4 |
|
T082815 |
|
otoline |
|
NLM (1974) |
|
C002540 |
|
miracil A |
|
1972 |
|
01 |
|
01 |
|
2003 |
|
08 |
|
08 |
|
structure in first source |
|
1 |
|
*ETHYLENEDIAMINES (72-75) |
|
*XANTHENES (72-75) |
|
D008154 |
|
Lucanthone |
|
*Q000031 |
|
analogs & derivatives |
|
Prog Drug Res 16:11;1972 |
|
M0043189 |
|
miracil A |
|
9H-Xanthen-9-one, 1-((2-(diethylamino)ethyl)amino)-4-methyl- |
|
3569-84-4 |
|
T073192 |
|
miracil A |
|
NLM (1972) |
|
C055240 |
|
Leakadine |
|
1988 |
|
04 |
|
20 |
|
2001 |
|
02 |
|
06 |
|
may contain 2-carbamoylaziridine |
|
8 |
|
*D001388 |
|
Aziridines |
|
Vopr Onkol 1988;34(2):192 |
|
M0155620 |
|
Leakadine |
|
91433-16-8 |
|
T185625 |
|
Leakadine |
|
NLM (1988) |
|
T185624 |
|
Leakadin |
|
NLM (1988) |
|
T185623 |
|
Leacadin |
|
NLM (1988) |
|
C060863 |
|
conduritol aziridine |
|
1989 |
|
10 |
|
04 |
|
2005 |
|
11 |
|
03 |
|
inhibits both alpha- and beta-glucosidases; structure given in first source |
|
2 |
|
*D001388 |
|
Aziridines |
|
D007294 |
|
Inositol |
|
*Q000031 |
|
analogs & derivatives |
|
D050112 |
|
Imino Pyranoses |
|
D001617 |
|
beta-Glucosidase |
|
Q000037 |
|
antagonists & inhibitors |
|
Biochem Biophys Res Commun 1989;163(1):495 |
|
M0168905 |
|
conduritol aziridine |
|
7-Azabicyclo(4.1.0)heptane-2,3,4,5-tetrol, (1alpha,2alpha,3beta,4alpha,5beta,6alpha)- |
|
123788-61-4 |
|
T198910 |
|
conduritol aziridine |
|
NLM (1989) |
|
T198909 |
|
1,2-dideoxy-1,2-iminoinositol |
|
NLM (1989) |
|
T198908 |
|
1,2-dideoxy-1,2-epimino-myo-inositol |
|
NLM (1989) |
|
C008725 |
|
1-oxacephalothin |
|
1975 |
|
01 |
|
01 |
|
structure |
|
0 |
|
D002512 |
|
Cephalothin |
|
*Q000031 |
|
analogs & derivatives |
|
J Am Chem Soc 96(24):7582;1974 |
|
M0052819 |
|
1-oxacephalothin |
|
5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, trans-(+-)- |
|
54214-84-5 |
|
T082822 |
|
1-oxacephalothin |
|
NLM (1975) |
|
C008727 |
|
oxaluric acid |
|
1974 |
|
01 |
|
01 |
|
1990 |
|
09 |
|
28 |
|
11 |
|
*OXALATES (74-75) |
|
AMIDES (74-75) |
|
CARBAMATES (74-82) |
|
D010072 |
|
Oxamic Acid |
|
*Q000031 |
|
analogs & derivatives |
|
J Bacteriol 117(3):1240;1974 |
|
M0052823 |
|
oxaluric acid |
|
585-05-7 |
|
M0052823 |
|
M0052821 |
|
M0052823 |
|
M0052822 |
|
T082826 |
|
oxaluric acid |
|
NLM (1974) |
|
M0052821 |
|
carbamoyloxamic acid |
|
M0052823 |
|
M0052821 |
|
T082824 |
|
carbamoyloxamic acid |
|
NLM (1974) |
|
M0052822 |
|
oxalurate |
|
M0052823 |
|
M0052822 |
|
T082825 |
|
oxalurate |
|
NLM (1974) |
|
C414549 |
|
MB21 peptide |
|
2000 |
|
10 |
|
24 |
|
2002 |
|
01 |
|
21 |
|
synthetic peptide with antimicrobial activity against a broad spectrum of microorganisms including various fungi; FYI - One other Medline citation (UI- 99402762 Appl Environ Microbiol 1999 Sep;65(9):4148-54) refers |
|
3 |
|
*D010455 |
|
Peptides |
|
Biochemistry 2000 Oct 3;39(39):11907-12 |
|
M0371423 |
|
MB21 peptide |
|
0 |
|
T427025 |
|
MB21 peptide |
|
2000 |
|
10 |
|
24 |
|
NLM (2000) |
|
T427026 |
|
Ac-MB21-NH2 |
|
2000 |
|
10 |
|
24 |
|
NLM (2000) |
|
T427027 |
|
FASLLGKALKALAKQ |
|
2000 |
|
10 |
|
24 |
|
NLM (2000) |
|
C008736 |
|
6-oxomestranol-6-(O-carboxymethyl)oxime |
|
1974 |
|
01 |
|
01 |
|
1982 |
|
09 |
|
03 |
|
0 |
|
*NORPREGNANES (74-79) |
|
*PREGNATRIENES (74-79) |
|
KETOSTEROIDS (74-79) |
|
OXIMES (74-82) |
|
D008656 |
|
Mestranol |
|
*Q000031 |
|
analogs & derivatives |
|
Steroids 22(3):327;1973 |
|
M0052843 |
|
6-oxomestranol-6-(O-carboxymethyl)oxime |
|
0 |
|
T082846 |
|
6-oxomestranol-6-(O-carboxymethyl)oxime |
|
NLM (1974) |
|
C008737 |
|
2-oxo-3-phenyl-1,2,3,4-tetrahydropyrido(2,3-c)pyrazine |
|
1974 |
|
01 |
|
01 |
|
1982 |
|
09 |
|
07 |
|
structure |
|
0 |
|
PYRIDINES (74-82) |
|
*D011719 |
|
Pyrazines |
|
J Med Chem 16(11):1296;1973 |
|
M0052844 |
|
2-oxo-3-phenyl-1,2,3,4-tetrahydropyrido(2,3-c)pyrazine |
|
3,4-dihydro-3-phenylpyrido(3,4-b)pyrazin-2(1H)-one |
|
43064-15-9 |
|
T082847 |
|
2-oxo-3-phenyl-1,2,3,4-tetrahydropyrido(2,3-c)pyrazine |
|
NLM (1974) |
|
C008738 |
|
9-oxoprostanoic acid |
|
1974 |
|
01 |
|
01 |
|
1975 |
|
01 |
|
01 |
|
structure |
|
0 |
|
*PROSTAGLANDINS (74-75) |
|
CYCLOPENTANES (74-75) |
|
FATTY ACIDS (74-75) |
|
*D011466 |
|
Prostanoic Acids |
|
Experientia 29(8):990;1973 |
|
M0052845 |
|
9-oxoprostanoic acid |
|
64122-56-1 |
|
T082848 |
|
9-oxoprostanoic acid |
|
NLM (1974) |
|
C008739 |
|
7-oxo-delta(1)-tetrahydrocannabinol |
|
1974 |
|
01 |
|
01 |
|
1975 |
|
01 |
|
01 |
|
aldehydic intermediate in metabolism of tetrahydrocannabinol; structure |
|
0 |
|
*TETRAHYDROCANNABINOL (74-75) |
|
ALDEHYDES (74-75) |
|
D013759 |
|
Dronabinol |
|
*Q000031 |
|
analogs & derivatives |
|
Res Commun Chem Pathol Pharmacol 8(2):223;1974 |
|
M0052846 |
|
7-oxo-delta(1)-tetrahydrocannabinol |
|
52663-85-1 |
|
T082849 |
|
7-oxo-delta(1)-tetrahydrocannabinol |
|
NLM (1974) |
|
C008722 |
|
methyl 6-(1,2,2-trichloroethenyl)imidazo(1,2-a)pyridine-2-carbamate |
|
1982 |
|
01 |
|
26 |
|
2001 |
|
02 |
|
05 |
|
structure in first source |
|
1 |
|
*D001562 |
|
Benzimidazoles |
|
J Med Chem 1981;24(12):1518 |
|
M0052817 |
|
methyl 6-(1,2,2-trichloroethenyl)imidazo(1,2-a)pyridine-2-carbamate |
|
Carbamic acid, (6-(trichloroethenyl)imidazo(1,2-a)pyridin-2-yl)-, methyl ester |
|
71820-94-5 |
|
T082820 |
|
methyl 6-(1,2,2-trichloroethenyl)imidazo(1,2-a)pyridine-2-carbamate |
|
NLM (1982) |
|
T082819 |
|
MTCE-IPC |
|
NLM (1982) |
|
C008746 |
|
30-oxyethylated t-octyl phenol formaldehyde tetramer |
|
1974 |
|
01 |
|
01 |
|
1997 |
|
08 |
|
13 |
|
reduces thromboatherosclerosis & cholesterol atherosclerosis; structure |
|
0 |
|
*D011092 |
|
Polyethylene Glycols |
|
D001161 |
|
Arteriosclerosis |
|
Q000188 |
|
drug therapy |
|
Exp Mol Pathol 20(2):154;1974 |
|
M0052859 |
|
30-oxyethylated t-octyl phenol formaldehyde tetramer |
|
12584-89-3 |
|
T082862 |
|
30-oxyethylated t-octyl phenol formaldehyde tetramer |
|
NLM (1974) |
|
C009879 |
|
estane plastic |
|
1975 |
|
01 |
|
01 |
|
2001 |
|
02 |
|
06 |
|
estane is urethane rubber |
|
8 |
|
*D011140 |
|
Polyurethanes |
|
Obstet Gynecol 45(3):287;1975 |
|
M0054951 |
|
estane plastic |
|
0 |
|
M0054951 |
|
M0054950 |
|
T084954 |
|
estane plastic |
|
NLM (1975) |
|
M0054950 |
|
Estane 5714 F1 |
|
M0054951 |
|
M0054950 |
|
T084953 |
|
Estane 5714 F1 |
|
NLM (1975) |
|
C008765 |
|
paracoccidioidin |
|
1974 |
|
01 |
|
01 |
|
1993 |
|
02 |
|
10 |
|
35 |
|
*ANTIGENS, FUNGAL (74-79) |
|
*COCCIDIOIDIN (74-92) |
|
PARACOCCIDIOIDES (74-79) |
|
*D005656 |
|
Fungal Proteins |
|
Am J Trop Med Hyg 23(1):87;1974 |
|
Sabouraudia 16(2):93;1978 |
|
M0052899 |
|
paracoccidioidin |
|
0 |
|
T082902 |
|
paracoccidioidin |
|
NLM (1974) |
|
C419503 |
|
plutonium hydroxide |
|
2001 |
|
02 |
|
06 |
|
1 |
|
*D011005 |
|
Plutonium |
|
Health Phys. 2001 Feb;80(2) :164-9 |
|
M0378031 |
|
plutonium hydroxide |
|
0 |
|
T435350 |
|
plutonium hydroxide |
|
2001 |
|
02 |
|
06 |
|
NLM (2001) |
|
T435352 |
|
(239)Pu-hydroxide |
|
2001 |
|
02 |
|
06 |
|
NLM (2001) |
|
T435351 |
|
(239)plutonium hydroxide |
|
2001 |
|
02 |
|
06 |
|
NLM (2001) |
|
C084722 |
|
3,6-dimethyl-2,5-diaziridinylhydroquinone |
|
1994 |
|
01 |
|
07 |
|
2001 |
|
02 |
|
06 |
|
hydroquinone form of the aziridinylbenzoquinone MeDZQ |
|
1 |
|
*D001388 |
|
Aziridines |
|
*D006873 |
|
Hydroquinones |
|
Biochemistry 1993 Nov 30;32(47):12857-63 |
|
M0225024 |
|
3,6-dimethyl-2,5-diaziridinylhydroquinone |
|
152923-07-4 |
|
T255029 |
|
3,6-dimethyl-2,5-diaziridinylhydroquinone |
|
NLM (1994) |
|
T255028 |
|
MeDZHQ |
|
NLM (1994) |
|
T255027 |
|
3,6-dimethyl-2,5-diaziridinyl-hydroquinone |
|
NLM (1994) |
|
C008784 |
|
pentafluorobenzylimine |
|
1974 |
|
01 |
|
01 |
|
1982 |
|
09 |
|
14 |
|
0 |
|
IMINES (74-82) |
|
*D005464 |
|
Fluorobenzenes |
|
J Chromatogr Sci 12(7):411;1974 |
|
M0052947 |
|
pentafluorobenzylimine |
|
0 |
|
T082950 |
|
pentafluorobenzylimine |
|
NLM (1974) |
|
C008786 |
|
3,5,5,O-3',5'-pentamethyl-2'-deoxydihydrouridine |
|
1974 |
|
01 |
|
01 |
|
1990 |
|
08 |
|
22 |
|
structure |
|
0 |
|
*DEOXYURIDINE (74-75) |
|
METHYL ETHERS (74-75) |
|
D003857 |
|
Deoxyuridine |
|
*Q000031 |
|
analogs & derivatives |
|
Biochim Biophys Acta 331(2):147;1973 |
|
M0052954 |
|
3,5,5,O-3',5'-pentamethyl-2'-deoxydihydrouridine |
|
0 |
|
M0052954 |
|
M0052953 |
|
T082957 |
|
3,5,5,O-3',5'-pentamethyl-2'-deoxydihydrouridine |
|
NLM (1974) |
|
M0052953 |
|
2'-deoxy-3,5,5,O-3',5'-pentamethyldihydrouridine |
|
M0052954 |
|
M0052953 |
|
T082956 |
|
2'-deoxy-3,5,5,O-3',5'-pentamethyldihydrouridine |
|
NLM (1974) |
|
C008796 |
|
S-pentyl-L-cysteine |
|
1974 |
|
01 |
|
01 |
|
1975 |
|
01 |
|
01 |
|
structure |
|
0 |
|
*CYSTEINE (74-75) |
|
D003545 |
|
Cysteine |
|
*Q000031 |
|
analogs & derivatives |
|
Xenobiotica 3(4):207;1973 |
|
M0052966 |
|
S-pentyl-L-cysteine |
|
4080-25-5 |
|
T082969 |
|
S-pentyl-L-cysteine |
|
NLM (1974) |
|
C008801 |
|
peptide PV |
|
1974 |
|
01 |
|
01 |
|
0 |
|
*D010456 |
|
Peptides, Cyclic |
|
J Gen Physiol 63(4):492;1974 |
|
M0052971 |
|
peptide PV |
|
Cyclic(D-prolyl-D-valyl-L-prolyl-L-valyl-D-prolyl-D-valyl-L-prolyl-L-valyl-D-prolyl-D-valyl-L-prolyl-L-valyl) |
|
38249-87-5 |
|
T082974 |
|
peptide PV |
|
NLM (1974) |
|
C008878 |
|
phosphatidylkojibiosyl diglyceride |
|
1975 |
|
01 |
|
01 |
|
2001 |
|
02 |
|
05 |
|
structure |
|
1 |
|
*PHOSPHOLIPIDS (75-76) |
|
DIGLYCERIDES (75-76) |
|
DISACCHARIDES (75-76) |
|
*D006017 |
|
Glycolipids |
|
*D010715 |
|
Phosphatidylglycerols |
|
J Biol Chem 250(2):702;1975 |
|
M0053107 |
|
phosphatidylkojibiosyl diglyceride |
|
0 |
|
T083110 |
|
phosphatidylkojibiosyl diglyceride |
|
NLM (1975) |
|
T083109 |
|
phosphatidylkojibiosyl diacylglycerol |
|
NLM (1975) |
|
C008826 |
|
phenacid |
|
1972 |
|
01 |
|
01 |
|
2001 |
|
01 |
|
12 |
|
RN given refers to parent cpd; structure |
|
17 |
|
PHENYLACETATES (72-82) |
|
*D009588 |
|
Nitrogen Mustard Compounds |
|
Biofizika 24(2):230;1979 |
|
Steroids 19(6):771;1972 |
|
M0053015 |
|
phenacid |
|
10477-72-2 |
|
40068-28-8 (Na salt) |
|
M0053015 |
|
M0310481 |
|
T083018 |
|
phenacid |
|
NLM (1972) |
|
T083017 |
|
phenylacetic mustard |
|
NLM (1972) |
|
T083016 |
|
p-(N,N-bis(2-chloroethyl)amino)phenylacetic acid |
|
NLM (1972) |
|
T083014 |
|
4-(N,N-bis(2-chloroethyl)amino)phenylacetic acid |
|
NLM (1972) |
|
T083015 |
|
chlorphenacyl |
|
NLM (1972) |
|
M0310481 |
|
phenacid, sodium salt |
|
40068-28-8 |
|
M0053015 |
|
M0310481 |
|
T340481 |
|
phenacid, sodium salt |
|
1999 |
|
08 |
|
18 |
|
NLM (1972) |
|
C008814 |
|
peroben |
|
1975 |
|
01 |
|
01 |
|
1982 |
|
08 |
|
02 |
|
hypnosedative combination of diphenhydramine & pyrithyldione |
|
0 |
|
*D004155 |
|
Diphenhydramine |
|
D004338 |
|
Drug Combinations |
|
*D011728 |
|
Pyridones |
|
Dermatologica 158(6):417;1979 |
|
Praxis 63(6):157;1974 |
|
M0052994 |
|
peroben |
|
2,4(1H,3H)-Pyridinedione, 3,3-diethyl-, mixt. with 2-(diphenylmethoxy)-N,N-dimethylethanamine |
|
78371-63-8 |
|
T082997 |
|
peroben |
|
NLM (1975) |
|
C008816 |
|
4-peroxycyclophosphamide |
|
1974 |
|
01 |
|
01 |
|
1982 |
|
09 |
|
07 |
|
1 |
|
*CYCLOPHOSPHAMIDE (74-75) |
|
PEROXIDES (74-82) |
|
D003520 |
|
Cyclophosphamide |
|
*Q000031 |
|
analogs & derivatives |
|
J Am Chem Soc 96(12):4014;1974 |
|
M0052996 |
|
4-peroxycyclophosphamide |
|
51274-71-6 |
|
T082999 |
|
4-peroxycyclophosphamide |
|
NLM (1974) |
|
C054080 |
|
lipid-associated sialic acid |
|
1987 |
|
12 |
|
14 |
|
2001 |
|
04 |
|
05 |
|
elevated in patients with metastatic spread of laryngeal cancer; plasma levels of LASA-P may be correlated to alteration of cancer cells' surface membranes and thus may serve as a useful marker for malignant melanoma |
|
67 |
|
*SIALIC ACIDS (87-96) |
|
*D008055 |
|
Lipids |
|
*D019158 |
|
N-Acetylneuraminic Acid |
|
D014408 |
|
Biomarkers, Tumor |
|
Clin Otolaryngol 1987;12(4):303 |
|
M0152917 |
|
lipid-associated sialic acid |
|
0 |
|
T182922 |
|
lipid-associated sialic acid |
|
NLM (1987) |
|
T182921 |
|
LASA-P |
|
NLM (1987) |
|
T182920 |
|
LASA |
|
NLM (1987) |
|
C103995 |
|
plaunotol M-6 |
|
1997 |
|
02 |
|
21 |
|
2001 |
|
04 |
|
05 |
|
RN given for (E,Z,E)-isomer; structure in first source |
|
2 |
|
*D005231 |
|
Fatty Acids, Unsaturated |
|
J Antimicrob Chemother 1996 Sep;38(3):387-97 |
|
M0271766 |
|
plaunotol M-6 |
|
65811-39-4 |
|
65811-42-9 ((Z,E,E)-isomer) |
|
M0271766 |
|
M0327738 |
|
T301771 |
|
plaunotol M-6 |
|
NLM (1997) |
|
M0327738 |
|
plaunotol M-6, (Z,E,E)-isomer |
|
65811-42-9 |
|
M0271766 |
|
M0327738 |
|
T357738 |
|
plaunotol M-6, (Z,E,E)-isomer |
|
1999 |
|
08 |
|
18 |
|
NLM (1997) |
|
C069989 |
|
serine containing aminolipid |
|
1991 |
|
08 |
|
21 |
|
2001 |
|
04 |
|
05 |
|
analog of ornithine containing aminolipid; rarely present in bacteria; protects mice form lethal endotoxemia |
|
6 |
|
*D008055 |
|
Lipids |
|
D012694 |
|
Serine |
|
*Q000031 |
|
analogs & derivatives |
|
Infect Immun 1991;59(8):2560 |
|
M0190832 |
|
serine containing aminolipid |
|
0 |
|
T220837 |
|
serine containing aminolipid |
|
NLM (1991) |
|
T220836 |
|
serine-containing lipid |
|
NLM (1991) |
|
T220835 |
|
Ser-L |
|
NLM (1991) |
|
C012409 |
|
lonetil M3 |
|
1976 |
|
01 |
|
01 |
|
2009 |
|
11 |
|
12 |
|
Russian Drug; structure |
|
10 |
|
D008702 |
|
Methaqualone |
|
*Q000031 |
|
analogs & derivatives |
|
Act Nerv Super (Praha) 18(3):198;1976 |
|
Eksp Med Morfol 15(2):79;1976 |
|
M0059417 |
|
lonetil M3 |
|
1897-96-7 |
|
M0059417 |
|
M0059415 |
|
M0059417 |
|
M0059416 |
|
T089420 |
|
lonetil M3 |
|
NLM (1976) |
|
M0059415 |
|
2-methyl-3(4-ethoxy)phenyl-4-quinazolone |
|
M0059417 |
|
M0059415 |
|
T089418 |
|
2-methyl-3(4-ethoxy)phenyl-4-quinazolone |
|
NLM (1976) |
|
M0059416 |
|
lonetil |
|
M0059417 |
|
M0059416 |
|
T089419 |
|
lonetil |
|
NLM (1976) |
|
C012411 |
|
lysometra |
|
1976 |
|
01 |
|
01 |
|
1982 |
|
07 |
|
01 |
|
polypeptide preparation; low MW polypeptides obtained from hydrolysis of animal organs |
|
0 |
|
*D010455 |
|
Peptides |
|
Curr Med Res Opin 4(2):151;1976 |
|
M0059425 |
|
lysometra |
|
0 |
|
T089428 |
|
lysometra |
|
NLM (1976) |
|
C012413 |
|
mastodynon |
|
1976 |
|
01 |
|
01 |
|
1982 |
|
07 |
|
06 |
|
plant extract used therapeutically in breast diseases; mastodynon composition: 100 g Agnus castus D1, 20 g Caulophyllum thalictroides D4, 10 g Cyclamen D4, 10 g Ignatia D6, 10 g Iris D2, 20 g Lillum tigrinum D3, 10 g Lupulinum D8, 10 g Tinctura Condurango, 10 g Hersteller: Bionorica KG. 85 Nurnberg 1 |
|
13 |
|
*D010936 |
|
Plant Extracts |
|
Fortschr Med 95(17):1175;1977 |
|
Med Welt 27(12):591;1976 |
|
ZFA (Stuttgart) 1979;55(22):1239 |
|
M0059426 |
|
mastodynon |
|
Mastodynon |
|
78200-25-6 |
|
T089429 |
|
mastodynon |
|
NLM (1976) |
|
C012421 |
|
3-methoxy-abeo-estrone |
|
1976 |
|
01 |
|
01 |
|
1983 |
|
10 |
|
07 |
|
0 |
|
HOMOSTEROIDS (76-83) |
|
D004970 |
|
Estrone |
|
*Q000031 |
|
analogs & derivatives |
|
Steroids 27(2):261;1976 |
|
M0059440 |
|
3-methoxy-abeo-estrone |
|
3-methoxy-9(10-19)abeo-1,3,5(10)-estratrien- 17-one |
|
0 |
|
T089443 |
|
3-methoxy-abeo-estrone |
|
NLM (1976) |
|
C012424 |
|
3 beta-methoxy-dinor-5-cholen-22-ol |
|
1976 |
|
01 |
|
01 |
|
metabolite of cholesteryl methyl ether; structure |
|
0 |
|
*D002770 |
|
Cholenes |
|
Acta Microbiol 22(4):447;1975 |
|
M0059443 |
|
3 beta-methoxy-dinor-5-cholen-22-ol |
|
0 |
|
T089446 |
|
3 beta-methoxy-dinor-5-cholen-22-ol |
|
NLM (1976) |
|
C012428 |
|
20-methylcholesterol |
|
1976 |
|
01 |
|
01 |
|
0 |
|
D002784 |
|
Cholesterol |
|
*Q000031 |
|
analogs & derivatives |
|
J Org Chem 41(13):2288;1976 |
|
M0059449 |
|
20-methylcholesterol |
|
Cholest-5-en-3-ol, 20-methyl-, (3beta)- |
|
58958-29-5 |
|
T089452 |
|
20-methylcholesterol |
|
NLM (1976) |
|
C012431 |
|
2-O-methyl-D-glucuronic acid |
|
1976 |
|
01 |
|
01 |
|
1982 |
|
07 |
|
12 |
|
0 |
|
METHYLGLYCOSIDES (76-82) |
|
*D005965 |
|
Glucuronates |
|
Biochem J 155(1):181;1976 |
|
M0059454 |
|
2-O-methyl-D-glucuronic acid |
|
D-Glucuronic acid, 2-O-methyl- |
|
59894-02-9 |
|
T089457 |
|
2-O-methyl-D-glucuronic acid |
|
NLM (1976) |
|
C012432 |
|
3-methyl-6-hydroxyquinazoline-2,4-dione |
|
1976 |
|
01 |
|
01 |
|
0 |
|
*D011799 |
|
Quinazolines |
|
C R Soc Biol (Paris) 169(5):1151;1975 |
|
M0059455 |
|
3-methyl-6-hydroxyquinazoline-2,4-dione |
|
17730-75-5 |
|
T089458 |
|
3-methyl-6-hydroxyquinazoline-2,4-dione |
|
NLM (1976) |
|
C012433 |
|
1-methylinosine |
|
1976 |
|
01 |
|
01 |
|
1979 |
|
11 |
|
29 |
|
20 |
|
D007288 |
|
Inosine |
|
*Q000031 |
|
analogs & derivatives |
|
Cancer 41(5):1685;1978 |
|
Clin Chim Acta 1979;97(2-3):159 |
|
J Am Chem Soc 98(9):2641;1976 |
|
Monogr Hum Genet 10:135;1978 |
|
M0059456 |
|
1-methylinosine |
|
2140-73-0 |
|
T089459 |
|
1-methylinosine |
|
NLM (1976) |
|
C012441 |
|
N-methyl-alpha-tocopheramine nitroxide |
|
1976 |
|
01 |
|
01 |
|
1995 |
|
03 |
|
30 |
|
structure |
|
0 |
|
*VITAMIN E (83-95) |
|
NITROGEN OXIDES (76-82) |
|
D014810 |
|
Vitamin E |
|
*Q000031 |
|
analogs & derivatives |
|
Lipids 11(4):296;1976 |
|
M0059462 |
|
N-methyl-alpha-tocopheramine nitroxide |
|
Nitroxide, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl methyl |
|
78249-60-2 |
|
T089465 |
|
N-methyl-alpha-tocopheramine nitroxide |
|
NLM (1976) |